 | Janux Therapeutics, Inc. | |||
| NGM : JANX || Location: United States | ||||
$47.1-1.11 (-2.3%) |
0.56 M | 45.68 - 48.3 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 3.443 M |
| March 28, 2024 | 3.754 M |
| March 15, 2024 | 3.111 M |
| Feb. 29, 2024 | 2.898 M |
| Feb. 15, 2024 | 2.436 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.40 | -0.25 | 37.59% |
| 09/30/2023 | -0.48 | -0.25 | 47.85% |
| 06/30/2023 | -0.53 | -0.42 | 20.42% |
| 03/31/2023 | -0.50 | -0.42 | 16.27% |
| 12/31/2022 | -0.50 | -0.39 | 21.40% |
JANX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 51.660M | Shares Float | 18.606M |
| Short Float | 3.443M | Market Cap | 2433.19M |
| Institution ownership | 83.25% | Insider ownership | 13.776% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.32 | Forward EPS | -1.64 |